1. Ye H, Rinkevich Y. Fascia layer-a novel target for the application of biomaterials in skin wound healing. Int J Mol Sci. 2023; 24(3): 2936. https://doi.org/10.3390/ijms24032936
2.
Yang Y, Huang J, Zeng A, Long X, Yu N, Wang X. The role of the skin microbiome in wound healing. Burns Trauma. 2024; 12: tkad059. https://doi.org/10.1093/burnst/tkad059
3.
Ferry T, Gogos C, Soriano A, Blasi F, Ansari W, Kantecki M, et al. Real-world use and treatment outcomes of Ceftaroline Fosamil in patients with complicated skin and soft tissue infection: a multinational retrospective study. Infect Drug Resist. 2024; 17: 2773-2783. https://doi.org/10.2147/IDR.S455515
4.
McDermott J, Kao LS, Keeley JA, Grigorian A, Neville A, de Virgilio C. Necrotizing soft tissue infections: a review. JAMA Surg. 2024; 159(11): 1308-1315. https://doi.org/10.1001/jamasurg.2024.3365
5.
Jones ME, Karlowsky JA, Draghi DC, Thornsberry C, Sahm DF, Nathwani D. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. International Journal of Antimicrobial Agents. 2003; 22(4): 406-419. https://doi.org/10.1016/S0924-8579(03)00154-7
6.
Mariani F, Galvan EM. Staphylococcus aureus in polymicrobial skin and soft tissue infections: impact of inter-species interactions in disease outcome. Antibiotics. 2023; 12(7): 1164. https://doi.org/10.3390/antibiotics12071164
7.
Gupta D. Bacterial skin and soft tissue infections in children. Pediatr Infect Dis. 2021; 3(4): 146-155. https://doi.org/10.5005/jp-journals-10081-1305
8.
Leong HN, Kurup A, Tan MY, Kwa AL, Liau KH, Wilcox M. Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics. Infection and Drug Resistance. 2018; 11: 1959-1974. https://doi.org/10.2147/IDR.S172366
9.
Simner PJ, Rauch CA, Martin IW, Sullivan KV, Rhoads D, Rolf R, et al. Raising the bar: improving antimicrobial resistance detection by clinical laboratories by ensuring use of current breakpoints. Open Forum Infect Dis. 2022; 9(3). https://doi.org/10.1093/ofid/ofac007
10.
Klinker KP, Hidayat LK, DeRyke CA, DePestel DD, Motyl M, Bauer KA. Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiograms. Ther Adv Infect Dis. 2021; 8: 20499361211011373. https://doi.org/10.1177/20499361211011373
11.
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 32nd ed. CLSI supplement M100. Wayne, PA: CLSI; 2022.
12.
Shen HN, Lu CL. Skin and soft tissue infections in hospitalized and critically ill patients: a nationwide population-based study. BMC Infectious Diseases. 2010; 10(1). https://doi.org/10.1186/1471-2334-10-151
13.
Barie PS, Eachempati SR. Surgical site infections. Surgical Clinics of North America. 2005; 85(6): 1115-1135. https://doi.org/10.1016/j.suc.2005.09.006
14.
Simner PJ, Hindler JA, Bhowmick T, Das S, Johnson JK, Lubers BV, et al. What's new in antibiograms? Updating CLSI M39 guidance with current trends. J Clin Microbiol. 2022; 60(10): e0221021. https://doi.org/10.1128/jcm.02210-21
15.
Kapil A. The challenge of antibiotic resistance: need to contemplate. Indian J Med Res. 2005; 121(2): 83-91.
16.
Wilcox MH, Dryden M. Update on the epidemiology of healthcare-acquired bacterial infections: Focus on complicated skin and skin structure infections. Journal of Antimicrobial Chemotherapy. 2021; 76(Suppl. 4): iv2–8. https://doi.org/10.1093/jac/dkab350
17.
Linz MS, Mattappallil A, Finkel D, Parker D. Clinical impact of Staphylococcus aureus skin and soft tissue infections. Antibiotics. 2023; 12(3): 557. https://doi.org/10.3390/antibiotics12030557
18.
Lestin-Bernstein F, Harberg R, Schumacher I, Briedigkeit L, Heese O, Biedermann K, et al. Staphylococcus aureus – selective reporting of antibiogram results and its impact on antibiotic use: interventional study with a reference group on the effect of switching from non-selective to selective antibiotic reporting. Antimicrob Resist Infect Control. 2021; 10(1): 157. https://doi.org/10.1186/s13756-021-01021-7
19.
Lade H, Kim JS. Molecular determinants of β-lactam resistance in methicillin-resistant Staphylococcus aureus (MRSA): an updated review. Antibiotics. 2023; 12(9): 1362. https://doi.org/10.3390/antibiotics12091362
20.
Hasan CM, Dutta D, Nguyen ANT. Revisiting antibiotic resistance: mechanistic foundations to evolutionary outlook. Antibiotics. 2022; 11(1): 40. https://doi.org/10.3390/antibiotics11010040
21.
Muteeb G, Rehman MT, Shahwan M, Aatif M. Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review. Pharmaceuticals. 2023; 16(11): 1615. https://doi.org/10.3390/ph16111615
22.
Ramakrishna MS, Jeyamani L, Abimannan GC, Vajravelu LK. Microbial profile and antibiogram pattern analysis of skin and soft tissue infections at a tertiary care center in South India. J Pure Appl Microbiol. 2021; 15(2): 915-25. https://doi.org/10.22207/JPAM.15.2.50
23.
Sartelli M, Malangoni MA, May AK, Viale P, Kao LS, Catena F, et al. World society of emergency surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg. 2014; 9(1). https://doi.org/10.1186/1749-7922-9-57
24.
Fiore E, Van Tyne D, Gilmore MS. Pathogenicity of enterococci. Microbiology Spectrum. 2019; 7(4). https://doi.org/10.1128/microbiolspec.GPP3-0053-2018
Copyright: © 2025 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
